Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Novartis AG

London - Acambis and Novartis were in a dispute over an experimental vaccine for yellow fever. The dispute arose over non-performance from a 1999 deal by predecessor companies acquired by Novartis. Acambis had US sales rights to the Arilvax vaccine and had previously completed Phase 3 clinical trials with a view to applying for a license in the US. Novartis has agreed to pay $19 million to settle the dispute over the Arilvax yellow fever vaccine. (Sep-12-06) [REUTERS]


Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.

Published on Sep-12-06


ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Legal Help Now! - Free